Smith-specific regulatory T cells halt the progression of lupus nephritis.

Autor: Eggenhuizen PJ; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Cheong RMY; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Lo C; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Chang J; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Ng BH; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Ting YT; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Monk JA; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Loh KL; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Broury A; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Tay ESV; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Shen C; Department of Hematology, The Affiliated Zhuzhou Hospital of Xiangya Medical College, Central South University, Zhuzhou, China., Zhong Y; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.; Department of Nephrology, Xiangya Hospital, Central South University, Changsha, China., Lim S; Alfred Research Alliance Flow Cytometry Core Facility, Melbourne, VIC, Australia., Chung JX; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Kandane-Rathnayake R; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Koelmeyer R; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Hoi A; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.; Department of Rheumatology, Monash Health, Clayton, VIC, Australia., Chaudhry A; Former Employee of Amgen, South San Francisco, CA, USA., Manzanillo P; Amgen Research, Amgen Inc, South San Francisco, CA, USA., Snelgrove SL; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia., Morand EF; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.; Department of Rheumatology, Monash Health, Clayton, VIC, Australia., Ooi JD; Centre for Inflammatory Diseases, Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia. Joshua.Ooi@monash.edu.

Publikováno v: Nature communications [Nat Commun] 2024 Feb 06; Vol. 15 (1), pp. 899. Date of Electronic Publication: 2024 Feb 06.

Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation.

Autor: Jin D; Department of Medicine, School of Clinical Sciences, Monash Univesity, Clayton, VIC, Australia., Loh KL; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, VIC, Australia., Shamekhi T; Department of Medicine, School of Clinical Sciences, Monash Univesity, Clayton, VIC, Australia., Ting YT; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, VIC, Australia., Lim Kam Sian TCC; Department of Medicine, School of Clinical Sciences, Monash Univesity, Clayton, VIC, Australia.; Monash Proteomics & Metabolomics Facility, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Roest J; St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia., Ooi JD; Centre for Inflammatory Diseases, Department of Medicine, Monash University, Monash Medical Centre, Clayton, VIC, Australia., Vivian JP; St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia. jvivian@svi.edu.au.; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia. jvivian@svi.edu.au., Faridi P; Department of Medicine, School of Clinical Sciences, Monash Univesity, Clayton, VIC, Australia.; Monash Proteomics & Metabolomics Facility, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2691, pp. 351-369.

Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility.

Autor: Wirasinha RC; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Davies AR; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.; Translational Research Unit, Department of Immunology, The Canberra Hospital, Canberra, Australia.; Centre for Personalised Immunology (NHMRC Centre of Research Excellence), John Curtin School of Medical Research, Australian National University, Canberra, Australia., Srivastava M; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia., Sheridan JM; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Australia., Sng XYX; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Delmonte OM; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Dobbs K; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Loh KL; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Miosge LA; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia., Lee CE; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.; Translational Research Unit, Department of Immunology, The Canberra Hospital, Canberra, Australia., Chand R; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.; Translational Research Unit, Department of Immunology, The Canberra Hospital, Canberra, Australia., Chan A; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Yap JY; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia., Keller MD; Division of Allergy and Immunology, Children's National Medical Center, Washington, DC., Chen K; Department of Pediatrics, University of Utah, Salt Lake City, UT.; Department of Pediatrics, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA., Rossjohn J; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Australia.; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK., La Gruta NL; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia., Vinuesa CG; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.; Centre for Personalised Immunology (NHMRC Centre of Research Excellence), John Curtin School of Medical Research, Australian National University, Canberra, Australia., Reid HH; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Australia., Lionakis MS; Fungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Notarangelo LD; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Gray DHD; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Australia., Goodnow CC; Garvan Institute of Medical Research & Cellular Genomics Futures Institute, University of New South Wales, Sydney, Australia., Cook MC; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.; Translational Research Unit, Department of Immunology, The Canberra Hospital, Canberra, Australia.; Centre for Personalised Immunology (NHMRC Centre of Research Excellence), John Curtin School of Medical Research, Australian National University, Canberra, Australia., Daley SR; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.

Publikováno v: The Journal of experimental medicine [J Exp Med] 2021 Feb 01; Vol. 218 (2).

High-Resolution HLA-DRB1 Allele Frequencies in a Romanian Cohort of Stem Cell Donors.

Autor: Caragea, MA^1,2 (AUTHOR), Ursu, IR³ (AUTHOR) dr.radu.ursu@gmail.com, Visan, DL² (AUTHOR), Maruntelu, I^1,2 (AUTHOR), Iordache, P⁴ (AUTHOR), Constantinescu, A¹ (AUTHOR), Tizu, M^1,2 (AUTHOR), Tălăngescu, A^1,2 (AUTHOR), Constantinescu, I^1,2 (AUTHOR)

Publikováno v: Balkan Journal of Medical Genetics. Jun2024, Vol. 27 Issue 1, p43-49. 7p.

The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis.

Autor: Ting YT; From the Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University, and., Petersen J; From the Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University, and.; the Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia., Ramarathinam SH; From the Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University, and., Scally SW; From the Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University, and., Loh KL; From the Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University, and., Thomas R; the University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane 4102, Australia., Suri A; the Janssen Research and Development, Pharmaceutical Companies of Johnson & Johnson, Turnhoutseweg 30, B-2340-Beerse, Belgium., Baker DG; the Janssen Research and Development, LLC, Spring House, Pennsylvania 19002, and., Purcell AW; From the Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University, and., Reid HH; From the Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University, and hugh.reid@monash.edu.; the Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia., Rossjohn J; From the Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University, and Jamie.rossjohn@monash.edu.; the Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia.; the Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff CF14 4XN, Wales, United Kingdom.

Publikováno v: The Journal of biological chemistry [J Biol Chem] 2018 Mar 02; Vol. 293 (9), pp. 3236-3251. Date of Electronic Publication: 2018 Jan 09.